{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:47:34Z","timestamp":1788310054900,"version":"build-2803163510"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Uncontrolled repetitive generalized tonic-clonic seizures (GTCS) are the main risk factor for sudden unexpected death in epilepsy (SUDEP). GTCS can be observed in models such as Pentylenetetrazole kindling (PTZ-K) or pilocarpine-induced Status Epilepticus (SE-P), which share similar alterations in cardiac function, with a high risk of SUDEP. Terminal cardiac arrhythmia in SUDEP can develop as a result of a high rate of hypoxic stress-induced by convulsions with excessive sympathetic overstimulation that triggers a neurocardiogenic injury, recently defined as \u201cEpileptic Heart\u201d and characterized by heart rhythm disturbances, such as bradycardia and lengthening of the QT interval. Recently, an iron overload-dependent form of non-apoptotic cell death called ferroptosis was described at the brain level in both the PTZ-K and SE-P experimental models. However, seizure-related cardiac ferroptosis has not yet been reported. Iron overload cardiomyopathy (IOC) results from the accumulation of iron in the myocardium, with high production of reactive oxygen species (ROS), lipid peroxidation, and accumulation of hemosiderin as the final biomarker related to cardiomyocyte ferroptosis. Iron overload cardiomyopathy is the leading cause of death in patients with iron overload secondary to chronic blood transfusion therapy; it is also described in hereditary hemochromatosis. GTCS, through repeated hypoxic stress, can increase ROS production in the heart and cause cardiomyocyte ferroptosis. We hypothesized that iron accumulation in the \u201cEpileptic Heart\u201d could be associated with a terminal cardiac arrhythmia described in the IOC and the development of state-potentially in the development of SUDEP. Using the aforementioned PTZ-K and SE-P experimental models, after SUDEP-related repetitive GTCS, we observed an increase in the cardiac expression of hypoxic inducible factor 1\u03b1, indicating hypoxic-ischemic damage, and both necrotic cells and hemorrhagic areas were related to the possible hemosiderin production in the PTZ-K model. Furthermore, we demonstrated for the first time an accumulation of hemosiderin in the heart in the SE-P model. These results suggest that uncontrolled recurrent seizures, as described in refractory epilepsy, can give rise to high hypoxic stress in the heart, thus inducing hemosiderin accumulation as in IOC, and can act as an underlying hidden mechanism contributing to the development of a terminal cardiac arrhythmia in SUDEP. Because iron accumulation in tissues can be detected by non-invasive imaging methods, cardiac iron overload in refractory epilepsy patients could be treated with chelation therapy to reduce the risk of SUDEP.<\/jats:p>","DOI":"10.3389\/fneur.2021.609236","type":"journal-article","created":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T08:42:56Z","timestamp":1613205776000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["Myocardial Iron Overload in an Experimental Model of Sudden Unexpected Death in Epilepsy"],"prefix":"10.3389","volume":"12","author":[{"given":"Enes","family":"Akyuz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuleyha","family":"Doganyigit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ece","family":"Eroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Moscovicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Merelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Lazarowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jer\u00f3nimo","family":"Auzmendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"E227","DOI":"10.1212\/WNL.0000000000007778","article-title":"SUDEP in the North American SUDEP registry: the full spectrum of epilepsies","volume":"93","author":"Verducci","year":"2019","journal-title":"Neurology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1212\/01.WNL.0000156352.61328.CB","article-title":"Case-control study of SUDEP","volume":"64","author":"Langan","year":"2005","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1684\/epd.2017.0891","article-title":"Sudden unexpected death in epilepsy (SUDEP): what every neurologist should know","volume":"19","author":"Shankar","year":"2017","journal-title":"Epileptic Disord"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S1474-4422(08)70202-3","article-title":"Sudden unexpected death in epilepsy: current knowledge and future directions","volume":"7","author":"Tomson","year":"2008","journal-title":"Lancet Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1528-1167.2011.03358.x","article-title":"Unifying the definitions of sudden unexpected death in epilepsy","volume":"53","author":"Nashef","year":"2012","journal-title":"Epilepsia"},{"key":"B6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1001\/archneur.55.6.857","article-title":"Patients with epilepsy who die suddenly have cardiac disease","volume":"55","author":"Natelson","year":"1998","journal-title":"Arch Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1212\/WNL.0000000000005740","article-title":"Incidence of cardiac fibrosis in SUDEP and control cases","volume":"91","author":"Devinsky","year":"2018","journal-title":"Neurology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1528-1157.1982.tb05079.x","article-title":"Autonomic dysfunction in epilepsy: characterization of autonomic cardiac neural discharge associated with pentylenetetrazol-induced epileptogenic activity","volume":"23","author":"Lathers","year":"1982","journal-title":"Epilepsia"},{"key":"B9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.eplepsyres.2013.10.018","article-title":"Relation of autonomic and cardiac abnormalities to ventricular fibrillation in a rat model of epilepsy","volume":"108","author":"Naggar","year":"2014","journal-title":"Epilepsy Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3390\/diagnostics10060388","article-title":"Investigating cardiac morphological alterations in a pentylenetetrazol-kindling model of epilepsy","volume":"10","author":"Akyuz","year":"2020","journal-title":"Diagnostics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e77843","DOI":"10.1371\/journal.pone.0077843","article-title":"Altered cardiac electrophysiology and sudep in a model of dravet syndrome","volume":"8","author":"Auerbach","year":"2013","journal-title":"PLoS ONE"},{"key":"B12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/ph11010021","article-title":"Pilocarpine-induced status epilepticus is associated with P-glycoprotein induction in cardiomyocytes, electrocardiographic changes, and sudden death","volume":"11","author":"Auzmendi","year":"2018","journal-title":"Pharmaceuticals"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2019.106590","article-title":"The role of P-glycoprotein (P-gp) and inwardly rectifying potassium (Kir) channels in sudden unexpected death in epilepsy (SUDEP)","author":"Auzmendi","year":"2019","journal-title":"Epilepsy Behav"},{"key":"B14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.14800\/mce.66","article-title":"Progressive heart P-glycoprotein (P-gp) overexpression after experimental repetitive seizures (ERS) associated with fatal status epilepticus (FSE). Is it related with SUDEP?","volume":"1","author":"Auzmendi","year":"2014","journal-title":"Mol Cell Epilepsy"},{"key":"B15","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s10571-020-00789-3","article-title":"Inhibition of USP15 prevent glutamate-induced oxidative damage by activating Nrf2\/HO-1 signaling pathway in HT22 cells","volume":"40","author":"Chen","year":"2020","journal-title":"Cell Mol Neurobiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1176\/pn.45.23.psychnews_45_23_048","article-title":"Oxidative stress and diabetes: a review","volume":"1","author":"Kangralkar","year":"2010","journal-title":"Int J Pharm Appl"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/nm920","article-title":"L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy","volume":"9","author":"Oudit","year":"2003","journal-title":"Nat Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1161\/01.RES.84.11.1302","article-title":"Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: possible implications in iron overload","volume":"84","author":"Tsushima","year":"1999","journal-title":"Circ Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12011-017-0957-7","article-title":"Zinc dyshomeostasis in cardiomyocytes after acute hypoxia\/reoxygenation","volume":"179","author":"Bodiga","year":"2017","journal-title":"Biol Trace Elem Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.freeradbiomed.2018.10.413","article-title":"Non-transferrin-bound iron transporters","volume":"133","author":"Knutson","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"18132","DOI":"10.1038\/srep18132","article-title":"Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy","volume":"5","author":"Das","year":"2015","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.3390\/ijms18112365","article-title":"Metabolic dysfunction and oxidative stress in epilepsy","volume":"18","author":"Pearson-Smith","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B23","unstructured":"21017\n            LorigadosL\n            MoralesLM\n            Orozco-Su\u00e1rezS\n            GallardoJM\n            D\u00edaz-HungML\n            Gonz\u00e1lezME\n          Oxidative stress in pharmacoresistant epilepsy332016"},{"key":"B24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","article-title":"Ferroptosis: death by lipid peroxidation","volume":"26","author":"Yang","year":"2016","journal-title":"Trends Cell Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1177\/019262339602400504","article-title":"Histopathological evaluation of liver, pancreas, spleen, and heart from iron-overloaded sprague-dawley rats*1,2","volume":"24","author":"Whittaker","year":"1996","journal-title":"Toxicol Pathol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1111\/epi.13765","article-title":"Obstructive apnea due to laryngospasm links ictal to postictal events in SUDEP cases and offers practical biomarkers for review of past cases and prevention of new ones","volume":"58","author":"Stewart","year":"2017","journal-title":"Epilepsia"},{"key":"B28","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.eplepsyres.2016.08.004","article-title":"Laryngospasm, central and obstructive apnea during seizures: defining pathophysiology for sudden death in a rat model","volume":"128","author":"Nakase","year":"2016","journal-title":"Epilepsy Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"104682","DOI":"10.1016\/j.nbd.2019.104682","article-title":"An oxygen-rich atmosphere or systemic fluoxetine extend the time to respiratory arrest in a rat model of obstructive apnea","volume":"134","author":"Mooney","year":"2020","journal-title":"Neurobiol Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S1474-4422(13)70214-X","article-title":"Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): a retrospective study","volume":"12","author":"Ryvlin","year":"2013","journal-title":"Lancet Neurol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3109\/00207454.2014.989321","article-title":"Erythropoietin as a new therapeutic opportunity in brain inflammation and neurodegenerative diseases","volume":"125","author":"Merelli","year":"2015","journal-title":"Int J Neurosci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.14715\/cmb\/2017.64.15.8","article-title":"Expression of cardiac inwardly rectifying potassium channels in pentylenetetrazole kindling model of epilepsy in rats","volume":"64","author":"Aky\u00fcz","year":"2018","journal-title":"Cell Mol Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2174\/1871527318666190801112027","article-title":"Spontaneous recurrent seizures mediated cardiac dysfunction via mTOR pathway upregulation: a putative target for SUDEP management","volume":"18","author":"Sharma","year":"2019","journal-title":"CNS Neurol Disord - Drug Targets"},{"key":"B34","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0735-1097(17)33586-6","article-title":"Acute and stable ischemic heart disease myocardial hemorrhage after coronary ischemia-reperfusion leads to an iron-mediated, self-perpetuating loop of foam cell and ceroid accumulation","volume":"69","author":"Cokic","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.jcmg.2011.08.016","article-title":"Detection and quantification of myocardial reperfusion hemorrhage using T2 (*)-weighted CMR","volume":"4","author":"Kumar","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1093\/eurheartj\/ehl059","article-title":"Magnetic resonance imaging of haemorrhage within reperfused myocardial infarcts: possible interference with iron oxide-labelled cell tracking?","volume":"27","author":"Van","year":"2006","journal-title":"Eur Heart J"},{"key":"B37","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1365-2141.2004.05202.x","article-title":"Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance","volume":"127","author":"Anderson","year":"2004","journal-title":"Br J Haematol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrm3495","article-title":"Molecular basis of physiological heart growth: fundamental concepts and new players","volume":"14","author":"Maillet","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"153269","DOI":"10.1016\/j.prp.2020.153269","article-title":"Autoptic findings of sudden cardiac death (SCD) in patients with arrhythmogenic ventricular cardiomiopathy (AVC) from left ventricle and biventricular involvement","volume":"216","author":"Mansueto","year":"2020","journal-title":"Pathol-Res Pract"},{"key":"B40","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10741-018-9756-2","article-title":"Mitochondrial membrane transporters and metabolic switch in heart failure","volume":"24","author":"Kumar","year":"2019","journal-title":"Heart Fail Rev"},{"key":"B41","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0002-9343(71)90240-3","article-title":"Iron in the heart. Etiology and clinical significance","volume":"51","author":"Buja","year":"1971","journal-title":"Am J Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0092-8674(04)00343-5","article-title":"Balancing acts: molecular control of mammalian iron metabolism","volume":"117","author":"Hentze","year":"2004","journal-title":"Cell"},{"key":"B43","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.10160","article-title":"Cell death in experimental intracerebral hemorrhage: the \u201cblack hole\u201d model of hemorrhagic damage","volume":"51","author":"Felberg","year":"2002","journal-title":"Ann Neurol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1152\/physrev.00022.2018","article-title":"Fundamental mechanisms of regulated cell death and implications for heart disease","volume":"99","author":"Del Re","year":"2019","journal-title":"Physiol Rev"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.111.050773","article-title":"Iron overload cardiomyopathy in clinical practice","volume":"124","author":"Kremastinos","year":"2011","journal-title":"Circulation"},{"key":"B46","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1536\/ihj.17-160","article-title":"Fatal cardiac hemochromatosis in a patient with hereditary spherocytosis","volume":"59","author":"Fujino","year":"2018","journal-title":"Int Heart J"},{"key":"B47","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.cardfail.2010.05.009","article-title":"Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment","volume":"16","author":"Murphy","year":"2010","journal-title":"J Card Fail"},{"key":"B48","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1161\/CIR.0b013e31829b2be6","article-title":"Cardiovascular function and treatment in \u03b2-thalassemia major: a consensus statement from the american heart association","volume":"128","author":"Pennell","year":"2013","journal-title":"Circulation"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2","DOI":"10.15761\/IMC.1000117","article-title":"Iron overload cardiomyopathy: a review of literature on clinical status and meta-analysis of diagnostic and clinical management using iron chelators","author":"Albakri","year":"2018","journal-title":"Intern Med Care"},{"key":"B50","doi-asserted-by":"publisher","first-page":"106946","DOI":"10.1016\/j.yebeh.2020.106946","article-title":"The epileptic heart: concept and clinical evidence","volume":"105","author":"Verrier","year":"2020","journal-title":"Epilepsy Behav"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1161\/CIRCULATIONAHA.109.874487","article-title":"Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major","volume":"120","author":"Kirk","year":"2009","journal-title":"Circulation"},{"key":"B52","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3978\/j.issn.2223-4292.2014.10.05","article-title":"Cardiovascular magnetic resonance T2* for tissue iron assessment in the heart","volume":"4","author":"He","year":"2014","journal-title":"Quant Imaging Med Surg"},{"key":"B53","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1532-429X-10-42","article-title":"Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance","volume":"10","author":"Modell","year":"2008","journal-title":"J Cardiovasc Magn Reson"},{"key":"B54","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4081\/vl.2012.e6","article-title":"Ulcerated hemosiderinic dyschromia and iron deposits within lower limbs treated with a topical application of biological chelator","volume":"1","author":"Brizzio","year":"2012","journal-title":"Veins Lymphat"},{"key":"B55","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.seizure.2019.07.002","article-title":"Epilepsy and ultra-structural heart changes: the role of catecholaminergic toxicity and myocardial fibrosis. What can we learn from cardiology?","volume":"71","author":"Fialho","year":"2019","journal-title":"Seizure"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.609236\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T08:43:07Z","timestamp":1613205787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.609236\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":55,"alternative-id":["10.3389\/fneur.2021.609236"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.609236","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]},"article-number":"609236"}}